Chemoinformaics analysis of (E)-2-Methyl-2-butenyl angelate
| Molecular Weight | 168.236 | nRot | 3 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 3 |
| Exact Molecular Weight | 168.115 | nRing | 0 |
| Solubility: LogS | -2.129 | nHRing | 0 |
| Solubility: LogP | 2.482 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.9727 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.367 |
| Synth | 2.911 |
| Natural Product Likeliness | 1.759 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.355 |
| MDCK | 0.0000265 |
| BBB | 0.883 |
| PPB | 0.856396 |
| VDSS | 1.363 |
| FU | 0.270265 |
| CYP1A2-inh | 0.932 |
| CYP1A2-sub | 0.793 |
| CYP2c19-inh | 0.803 |
| CYP2c19-sub | 0.742 |
| CYP2c9-inh | 0.313 |
| CYP2c9-sub | 0.157 |
| CYP2d6-inh | 0.485 |
| CYP2d6-sub | 0.171 |
| CYP3a4-inh | 0.088 |
| CYP3a4-sub | 0.266 |
| CL | 10.883 |
| T12 | 0.836 |
| hERG | 0.011 |
| Ames | 0.03 |
| ROA | 0.015 |
| SkinSen | 0.929 |
| Carcinogencity | 0.043 |
| EI | 0.992 |
| Respiratory | 0.499 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.937105 |